See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
New River Pharmaceuticals Inc. (NRPH)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: NRPH
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on NRPH
Centient Biotech Investor
(10 followers)
Biotech Day in Review: New River/Shire Win Approval for ADHD Drug
(Tue, Feb 27)
Biotech Day in Review: Shire Buys New River for $2.6 Billion
(Wed, Feb 21)
More by Centient Biotech Investor on NRPH »
George Gutowski
(25 followers)
Weekend Follies: Press Releases While Nobody’s Looking
(Mon, Jun 19)
More by George Gutowski on NRPH »
SA Editor Miriam Metzinger
(560 followers)
Jim Cramer's Mad Money Lightning Round Picks, Feb. 21
(Wed, Feb 21)
More by SA Editor Miriam Metzinger on NRPH »
Most followed authors on NRPH
Joseph Shaefer
(2623 followers)
Global Warming: Investment Implications
(Thu, Aug 20)
More by Joseph Shaefer on NRPH »
SA Editor Miriam Metzinger
(560 followers)
Jim Cramer's Mad Money Lightning Round Picks, Feb. 21
(Wed, Feb 21)
More by SA Editor Miriam Metzinger on NRPH »
Stockerblog
(457 followers)
Analysis of a Ten Bagger Stock: New River Pharmaceuticals
(Mon, Feb 12)
More by Stockerblog on NRPH »
Newest authors on NRPH
Joseph Shaefer
(2623 followers)
Global Warming: Investment Implications
(Thu, Aug 20)
More by Joseph Shaefer on NRPH »
Mark Senak
(1 follower)
FDA Approvable Letters for New River Pharmaceuticals, Shire, Allergan and Perrigo
(Sun, Dec 24)
More by Mark Senak on NRPH »
Centient Biotech Investor
(10 followers)
Biotech Day in Review: New River/Shire Win Approval for ADHD Drug
(Tue, Feb 27)
Biotech Day in Review: Shire Buys New River for $2.6 Billion
(Wed, Feb 21)
More by Centient Biotech Investor on NRPH »
Most commented on NRPH
Joseph Shaefer
(2623 followers)
Global Warming: Investment Implications
(Thu, Aug 20)
More by Joseph Shaefer on NRPH »